TFRC and interstitial lung disease: CD71 has been shown to be highly expressed on human AMs in multiple contexts; alterations in numbers of CD71-expressing AMs have been reported in sarcoidosis and hypersensitivity pneumonitis (20), as well as in ILD cohorts (21).